| |
| |
|
| Insider
Information: |
Barrett Peter |
| Relationship: |
Director |
| City: |
Cambridge |
| State: |
MA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
8 |
|
| Direct
Shares |
4,667,117 |
|
|
Indirect Shares
|
23,288,256 |
|
|
| Direct
Value |
$7,881,992 |
|
|
|
Indirect Value
|
$8,020,209 |
|
|
| Total
Shares |
27,955,373 |
|
|
| Total
Value |
$15,902,201 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
1
|
|
Stock
price went up :
|
0
|
1
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
1.0
|
| Percentage
Gain/Loss : |
0.0%
|
 40.3%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Alnylam Pharmaceuticals Inc |
ALNY |
Director |
2005-09-29 |
189 |
2006-03-07 |
5,293 |
Premium* |
|
|
Momenta Pharmaceuticals Inc |
MNTA |
Director, 10% Owner |
2004-06-21 |
0 |
2005-08-03 |
379 |
Premium* |
|
|
Helicos Biosciences Corp |
HLCSQ |
Director, 10% Owner |
2007-05-30 |
0 |
2009-09-18 |
11,851,387 |
Premium* |
|
|
Sciclone Pharmaceuticals Inc |
SCLN |
Director |
|
0 |
2011-04-18 |
1,972,189 |
Premium* |
|
|
Perkinelmer Inc |
PKI |
|
2024-05-01 |
23,601 |
2012-05-01 |
0 |
Premium* |
|
|
Larimar Therapeutics Inc |
LRMR |
Director, 10% Owner |
2016-01-25 |
4,643,327 |
2014-06-24 |
5,632,730 |
Premium* |
|
|
Vitae Pharmaceuticals, Inc |
VTAE |
Director |
2014-09-29 |
0 |
2014-09-29 |
1,174,315 |
Premium* |
|
|
Synlogic Inc |
SYBX |
Director |
|
0 |
2017-08-28 |
2,651,963 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
55 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 3
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| SCLN |
Sciclone Pharmaceuticals ... |
Director |
– • – |
2011-04-18 |
3 |
IO |
$0.00 |
$0 |
I/I |
0 |
1,972,189 |
|
- |
|
| SYBX |
Synlogic Inc |
Director |
– • – |
2017-08-28 |
3 |
IO |
$0.00 |
$0 |
I/I |
0 |
2,651,963 |
|
- |
|
| ALNY |
Alnylam Pharmaceuticals I... |
Director |
– • • |
2004-06-03 |
4 |
A |
$0.00 |
$0 |
I/I |
1,783,692 |
21,084 |
|
- |
|
| MNTA |
Momenta Pharmaceuticals I... |
Director |
– • • |
2004-06-25 |
4 |
A |
$0.00 |
$0 |
I/I |
3,680,387 |
39,827 |
|
- |
|
| MNTA |
Momenta Pharmaceuticals I... |
Director |
– • • |
2005-07-05 |
4 |
D |
$0.00 |
$0 |
I/I |
(760,477) |
31,862 |
|
- |
|
| MNTA |
Momenta Pharmaceuticals I... |
Director |
– • • |
2005-08-03 |
4 |
A |
$0.00 |
$0 |
I/I |
379 |
379 |
|
- |
|
| MNTA |
Momenta Pharmaceuticals I... |
Director |
– • • |
2005-08-03 |
4 |
D |
$0.00 |
$0 |
I/I |
(582,810) |
25,725 |
|
- |
|
| ALNY |
Alnylam Pharmaceuticals I... |
Director |
– • • |
2005-09-29 |
4 |
D |
$0.00 |
$0 |
I/I |
(668,731) |
14,057 |
|
- |
|
| ALNY |
Alnylam Pharmaceuticals I... |
Director |
– • • |
2005-09-29 |
4 |
A |
$0.00 |
$0 |
D/D |
189 |
189 |
|
- |
|
| HLCSQ |
Helicos Biosciences Corp |
Director |
– • • |
2007-05-30 |
4 |
A |
$0.00 |
$0 |
I/I |
2,654,433 |
2,654,433 |
0 |
- |
|
| HLCSQ |
Helicos Biosciences Corp |
Director |
– • • |
2008-12-23 |
4 |
B |
$0.00 |
$0 |
I/I |
8,620,690 |
11,608,456 |
2.17 |
- |
|
| HLCSQ |
Helicos Biosciences Corp |
Director |
– • • |
2009-09-18 |
4 |
B |
$0.00 |
$0 |
I/I |
242,931 |
11,851,387 |
2.17 |
- |
|
| PKI |
Perkinelmer Inc |
Director |
– • – |
2012-05-01 |
4 |
A |
$0.00 |
$0 |
D/D |
3,580 |
4,535 |
0 |
- |
|
| PKI |
Perkinelmer Inc |
Director |
– • – |
2013-04-30 |
4 |
A |
$0.00 |
$0 |
D/D |
3,263 |
7,798 |
0 |
- |
|
| PKI |
Perkinelmer Inc |
Director |
– • – |
2014-04-29 |
4 |
A |
$0.00 |
$0 |
D/D |
2,373 |
10,171 |
0 |
- |
|
| LRMR |
Larimar Therapeutics Inc |
Director |
– • – |
2014-06-24 |
4 |
A |
$0.00 |
$0 |
I/I |
5,632,730 |
5,632,730 |
0 |
- |
|
| VTAE |
Vitae Pharmaceuticals, In... |
Director |
– • – |
2014-09-29 |
4 |
A |
$0.00 |
$0 |
I/I |
1,136,815 |
1,136,815 |
0 |
- |
|
| PKI |
Perkinelmer Inc |
Director |
– • – |
2015-05-05 |
4 |
A |
$0.00 |
$0 |
D/D |
3,033 |
13,204 |
0 |
- |
|
| PKI |
Perkinelmer Inc |
Director |
– • – |
2016-05-10 |
4 |
A |
$0.00 |
$0 |
D/D |
3,194 |
16,398 |
0 |
- |
|
| PKI |
Perkinelmer Inc |
Director |
– • – |
2017-05-09 |
4 |
A |
$0.00 |
$0 |
D/D |
2,802 |
19,200 |
0 |
- |
|
| PKI |
Perkinelmer Inc |
Director |
– • – |
2018-05-03 |
4 |
A |
$0.00 |
$0 |
D/D |
2,429 |
21,629 |
0 |
- |
|
| PKI |
Perkinelmer Inc |
Director |
– • – |
2019-04-30 |
4 |
A |
$0.00 |
$0 |
D/D |
1,828 |
23,457 |
0 |
- |
|
| PKI |
Perkinelmer Inc |
Director |
– • – |
2019-11-11 |
4 |
GD |
$0.00 |
$0 |
D/D |
955 |
22,502 |
0 |
- |
|
| PKI |
Perkinelmer Inc |
Director |
– • – |
2021-05-07 |
4 |
A |
$0.00 |
$0 |
D/D |
1,313 |
23,314 |
0 |
- |
|
| PKI |
Perkinelmer Inc |
Director |
– • – |
2021-07-30 |
4 |
GD |
$0.00 |
$0 |
D/D |
5,000 |
18,314 |
0 |
- |
|
55 Records found
|
|
Page 1 of 3 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
